文献速递免疫规划传染病防控与疫情报告

Eg95与TM16 mRNA疫苗单次免疫小鼠的免疫应答初步评价

Primary evaluation of immune responses in mice after a single mRNA immunization with Echinococcus granulosus Eg95 and Coenurus cerebralis TM16.
PubMed 文献 · Vaccine · 2026-01-21

研究针对细粒棘球绦虫Eg95和脑多头蚴TM16抗原,开发重组蛋白疫苗与mRNA-LNP疫苗,单次免疫BALB/c小鼠后评估免疫应答。两种疫苗均显著升高特异性抗体(IgG、IgG1、IgG2a)和细胞因子(IFN-γ、IL-4)(P < 0.001),诱导以Th1型为主的免疫反应;mRNA-LNP疫苗在提升IgG2a水平和CD8+ T细胞应答方面优于蛋白疫苗。

要点

  • Eg95与TM16 mRNA-LNP单次免疫可显著升高小鼠特异性IgG、IgG1、IgG2a(P < 0.001)。
  • 两种疫苗均升高IFN-γ和IL-4(P < 0.001),诱导Th1型为主免疫应答。
  • mRNA-LNP疫苗增强IgG2a和CD8+ T细胞应答优于蛋白疫苗。

核心结论

  • Eg95-TM16 mRNA-LNP疫苗在小鼠中显示强免疫原性,支持在羊、山羊等中间宿主中进一步评价。

研究设计与样本

  • 研究开发针对Eg95和TM16抗原的重组蛋白疫苗与mRNA-LNP疫苗,单次免疫BALB/c小鼠后评估免疫应答。

主要发现

  • 两种疫苗均显著升高特异性抗体IgG、IgG1、IgG2a和细胞因子IFN-γ、IL-4(P < 0.001),诱导以Th1型为主的免疫反应。
  • mRNA-LNP疫苗在增强IgG2a水平和CD8+ T细胞应答方面优于蛋白疫苗。

临床怎么用

  • 结果提示Eg95-TM16 mRNA-LNP疫苗值得在羊、山羊等中间宿主中进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Echinococcus granulosus and Taenia multiceps cause zoonotic cystic diseases. Studies have shown that Eg95 from E. granulosus is highly conserved, exhibits excellent immunogenicity, and serves as a critical candidate antigen. In recent years, the TM16 recombinant protein antigen has been one of the most studied antigens for preventing C. cerebralis and demonstrates optimal experimental immunogenicity. This study developed both recombinant protein and mRNA-LNP vaccines targeting the Eg95 and TM16 antigens. Immunization of BALB/c mice showed that both vaccines significantly increased specific antibody levels (IgG, IgG1, IgG2a) and cytokines (IFN-γ, IL-4) (P < 0.001), inducing a predominant Th1-type immune response. The mRNA-LNP vaccine demonstrated superior efficacy in enhancing IgG2a levels and CD8+ T cell responses compared to the protein vaccine. These results indicate strong immunogenicity and support further evaluation of the Eg95-TM16 mRNA-LNP vaccine in intermediate hosts like sheep and goats.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Meng CN, Li TT, Li WH, et al. Primary evaluation of immune responses in mice after a single mRNA immunization with Echinococcus granulosus Eg95 and Coenurus cerebralis TM16. Vaccine. 2026. PMID: 41570444. doi:10.1016/j.vaccine.2026.128232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。